April 2007

NCCCS BioNetworkCutting-Edge Workforce TrainingWhen announcing Novartis' new vaccine-manufacturing facility at Holly Springs, NC, CEO Joerge Reinhardt said, "The fact that we can have instantaneous workers was absolutely essential. It was the main reason why we picked North Carolina." The NC Community College System (NCCCS) BioNetwork is providing that workforce for Novartis and the hundreds of other companies that make North Carolina the number-three biotech state in the United States. NC

By Meredith SmallCOMPANIES SUPPORTING OTHER COMPANIESIn the biotechnology world, service groups pick up crucial aspects from development through sales.Mark WickerJASON VARNEY | VARNEYPHOTO.COM In Greensboro, NC, Mark Wicker runs his own company, Carolina Research Glass, where he produces one-of-a-kind, hand-blown laboratory glass. One of only 600 scientific glass blowers in the country, Wicker works in Pyrex and produces about 500 objects a month. "I make drug- and aerosol-delivery devices, is

In our May issue, contributor Jerry Guo traveled to the Wolong Nature Reserve in China's Sichuan Province to learn what researchers there are doing to increase the panda population. Here, see the pandas at play ? and what they leave behind.

State of North CarolinaOffice of the Governor20301 Mail Service Center • Raleigh, NC 27699-0301Michael F. EasleyGovernorFebruary 26, 2007Dear Readers:Almost 25 years ago, North Carolina led the way to build a new economic engine called biotechnology. We created the world's first government-sponsored biotechnology center and began making systematic, long-term State investments in biotechnology infrastructure.Today North Carolina is the nation's third largest biotech state, with more than 350

Tarheel Teamwork Today's science depends on teamwork as experts from many fields come together. North Carolina's business leaders, government officials, and scientists started working together decades ago, and the results appear in the state's already powerful and continually growing science community. This section explores the history behind North Carolina's commitment to science, including the creation in 1959 of the 7,000 acre Research Triangle Park roughly in the center of the state. A qua

By Dennis MeredithTHE STATE OF LIFE SCIENCENorth Carolina combines academic, industrial, government, and private resources to drive research, development, and manufacturing A half century ago, the world was only beginning to grasp the stunning implications of Watson's and Crick's double-helix DNA structure. Amidst those earliest glimmerings of the genetic revolution, North Carolina was already laying the foundation for its 21st-century success in biotechnology. In 1959, however, the evidence o

By Angela SpiveyTHE SEEDS OF GROWTHThree governors help harvest the benefits of biotechnology.Governor Jim Martin© ASSOCIATED PRESSIt was 1977, and Jim Hunt, the newly elected governor of North Carolina, was determined that his traditionally agricultural state would start growing a more fruitful economy. "Early in his first term, Hunt clearly sent out a signal across the state that he was interested in higher-paying jobs," says Ferrel Guillory, who covered Hunt's governorship for the Raleigh New

By Mike May - Guest EditorTURNING TEAMWORK INTO BIOTECHA decade or two ago, North Carolina was known for few things: tobacco farming, furniture building, and the first flight of the Wright brothers. Most of all, North Carolina held a reputation as the training ground for astounding basketball players, including Grant Hill, Michael Jordan, David Thompson, and many others. The cognoscenti, however, imagined a new status for the state. Even as early as the mid-20th century, teams of academic scient

STATEWIDE SCIENCE In many respects, the dividing line between academics and industry blurs across many areas of North Carolina. As depicted here, this state provides a home for some of the most powerful research institutions in the world. Much of the academic work, however, leads to new applications, as shown here in the work on stem cells by Anthony Atala of the Wake Forest University School of Medicine's Institute for Regenerative Medicine and the genetic approach to diseases taken by Ol

Slideshow: The whirling fish kill Andrea Gawrylewski visits a western Maryland fishery as workers haul nearly 40,000 pounds of rainbow trout infected with whirling disease out of the raceways. var FO = { movie:"http://www.the-scientist.com/supplementary/flash/53046/fishy.swf", width:"550", height:"450", majorversion:"8", build:"0", xi:"true"}; UFO.create(FO, "ufoDemo"); Please download the Adobe Flash Player to view this content:

By Russ CampbellTHE STATE OF ACADEMIC RESEARCHWorking together drives academic projects across the state. Several years ago, Duke University created a task force to look at the study of the psychological sciences around its campus in Durham, NC. "A question came up on whether the departments should be merged," says James N. Siedow, vice provost for research at Duke. "There was really good psychological research going on all over campus, but there was nothing tying everyone together. So ever

By Russ CampbellTHE STATE OF ACADEMIC RESEARCHWorking together drives academic projects across the state. Several years ago, Duke University created a task force to look at the study of the psychological sciences around its campus in Durham, NC. "A question came up on whether the departments should be merged," says James N. Siedow, vice provost for research at Duke. "There was really good psychological research going on all over campus, but there was nothing tying everyone together. So ever

Credit: © SHARON MORRIS" /> Credit: © SHARON MORRIS In the 1940s Jules Freund, inventor of Freund's adjuvant, worked on developing antibodies in horse to rabbit serum globulin. In a 1947 Journal of Experimental Medicine study, Freund describes the horses by number: 1026, 999, 1127. To others, they had names like Sylvester, Moses, and Doc Fried. The horses had retired from the New York City police department to reside at stables on a 170-acre plot of land in the tiny tow

Wake Forest University Health SciencesA Research and Economic EngineLast April, Kaitlyne McNamara walked across TV screens and into the hearts and imaginations of millions of viewers around the world. A victim of spina bifida since birth, Kaitlyne was finally living a more normal life after suffering for years with a tiny bladder. That story - about the world's first successful implantation of laboratory-grown organs in humans - was big news in 2006. Such big news, in fact, that Discover magazin

North Carolina State UniversityIt's lunchtime on the brickyard plaza at North Carolina State University, and the chatter includes impassioned discussions of research and learning. A chemistry professor and a graduate student debate the meaning of their newest data, while a cluster of entomology and genetics students practice French conversation over sandwiches. Budding industrial engineers discuss information extraction from three-dimensional images. Based on the conversations, any passerby

By Kendall MorganEIGHTY YEARS IN THE MAKINGThe life of a genetics pioneerOLIVER SMITHIES JASON VARNEY | VARNEYPHOTO.COM As a child in England in the 1930s, Oliver Smithies found his path before he knew that "science" was its name. "I remember, as a six- or seven-year-old, fairly clearly, that I wanted to be an inventor," says Smithies, who is Excellence Professor of Pathology at the University of North Carolina at Chapel Hill. "In a sense, that's what I've been ever since. I've invente

By Mike MayTHE STATE OF INDUSTRIAL RESEARCHNorth Carolina's industry rejuvenates traditional fields and spurs new ones. Harry Hart understands that traditional crops, corn and tobacco, can no longer sustain his family farm. In fields that once lay fallow in the winter, Hart now cultivates the cool-weather canola plant, whose seeds are rich in oil. In his own backyard, Hart extracts the oil and mixes it with methanol and a catalyst in 50-gallon drums to produce a clean-burning biodiesel fuel

var FO = { movie:"http://www.the-scientist.com/supplementary/flash/53044/player.swf", width:"550", height:"550", majorversion:"8", build:"0", xi:"true"}; UFO.create(FO, "ufoDemo"); Please download the Adobe Flash Player to view this content:

3-D Neurogenesis: Catch a 3-D glimpse of new neurons in the brain This spinning 40-micron section of rat hippocampus shows new neurons in the granule cell layer of the dentate gyrus. Mature neurons are labeled in green with NeuN and proliferating cells are labeled in red with BrDU. The video was generated by BrainCells Inc, a La Jolla, Calif. company searching for new antidepressant drugs based on their ability to stimulate neurogenesis in the hippocampus. All antidepressants on the mark

Growing a New Antidepressant Nine years ago, Rusty Gage shattered a neuroscience dogma when he showed human brains give birth to new neurons. Today, a company is eager to take those findings to the clinic.By Kerry Grens ARTICLE EXTRAS 1 and Liz Gould and Bruce McEwen at Rockefeller had published a suite of studies on the effects of stress on neurogenesis in rodents.2 But the field was sparkling wi

A HARSH DECREE Everything may die, nothing may be regenerated ARTICLE EXTRAS1 "I think it really was a turning point in the acceptance of the phenomenon as being real," Gould says. In the late 1990s Gould observed neurogenesis in the adult tree shrew as well,2 but the question remained: Did it occur in humans? "For us to believe it's more than an epiphenomenon, we needed to see if it occurs in humans," Gage s

Talecris Biotherapeutics

Talecris BiotherapeuticsYou would be excused for supposing that Talecris Biotherapeutics, Inc., founded on April 1, 2005, is a young company. In truth, though, its roots go much deeper - both scientifically and into the North Carolina Piedmont - than might be obvious at first glance. Talecris was formed when two private investment firms provided the capital to acquire the blood-plasma business of Bayer HealthCare LLC's Biological Products Division. Among those assets were Bayer's state-of-the-ar

The paper trail By Kerry Grens ARTICLE EXTRAS Growing a New Antidepressant A Harsh DecreeBrain Cells Video 1928 Histologist and Nobel laureate Santiago Ramon y Cajal writes in Degeneration and Regeneration in the Nervous System, "In adult centers the nerve paths are something fixed, ended, immutable. Everything may die, nothing may be regenerated." San

By John V. BoyneCALLING IN CROP SCIENCETop agricultural companies make North Carolina home. John V. Boyne is director of communications at Bayer CropScience. To know why three of the world's top crop-science companies selected North Carolina for their North American headquarters, look at the example of Bayer CropScience. According to Bill Buckner, president and CEO of Bayer CropScience's US operations, "You can't beat North Carolina in terms of loc

By Frank DillerTHE STATE OF SPINOFFSThree different beginnings show the variety of ways to evolve from an idea to a company. In the late 1990s, scientists from R.J. Reynolds Tobacco Company published many papers and abstracts about neuronal nicotinic receptors (NNRs). Knowing that such receptors respond to nicotine explains why a tobacco company would study them. Moreover, some research indicates that NNRs could play a role in tobacco's toxic effects. For example, bronchial epithelial cells

The Death of Faith? Darwin's theory was part of a larger cultural shift towards naturalistic philosophy. Why is he still the target of so many attacks?By Brendan Maher ARTICLE EXTRASSPRING BOOKSStem Cells on ShelvesAn Awkward SymbiosisHigh in the TreesBloody IsleThe Enchantment of EnhancementBooks about BodiesNew Lab Man

An Awkward Symbiosis Can fiction and scientific autobiography coexist? By Jennifer Rohn ARTICLE EXTRAS SPRING BOOKS Stem Cells on Shelves The Death of Faith? High in the Trees Bloody Isle The Enchantment of Enhancement Books about Bodies New Lab Manuals In Brief Luminous Fish: Tales of Science

High in the Trees What can you learn about ecosystems from the top of a 100 meter redwood?By Andrea Gawrylewski ARTICLE EXTRASSPRING BOOKSStem Cells on ShelvesAn Awkward SymbiosisThe Death of Faith?Bloody IsleThe Enchantment of EnhancementBooks about BodiesNew Lab ManualsIn Brief The Wild Trees: A Story of Passion and Daring, By Richar

Bloody Isle When genetics and history compete, who wins?By Newamul Khan ARTICLE EXTRASSPRING BOOKSStem Cells on ShelvesAn Awkward SymbiosisThe Death of Faith?High in the TreesThe Enchantment of EnhancementBooks about BodiesNew Lab ManualsIn Brief Saxons, Vikings, and Celts: The Genetic Roots of Britain and Ireland, By Bryan Sykes, 320

By Myrna F. WatanabeSUCCESS IN TWO CAREERSCultivating an eye for targets. DANI BOLOGNESI JASON VARNEY | varneyphoto.com By all accounts, Dani Bolognesi has been tremendously successful. His Duke University laboratory did the early work on identifying anti-HIV activity in what would become AZT (zidovudine), the first drug developed against the disease. In March 2003, the Food and Drug Administration approved Fuzeon, an HIV fusion-inhibitor drug that cam

By Ed FieldTHE STATE OF REGENERATIVE MEDICINENorth Carolina has the resources, but needs a plan to advance. Ed Field is president and CEO of Aldagen, a clinical stage, regenerative medicine company in Durham, NC JASON VARNEY | VARNEYPHOTO.COM One of the most promising forms of emerging therapy is the use of a person's own or a donor's cells to treat a variety of diseases. This approach, often called cell therapy and more recently regenerative medici

The Enchantment of Enhancement Just because we can create superhumans, should we? By Faith McLellan ARTICLE EXTRASSPRING BOOKSStem Cells on ShelvesAn Awkward SymbiosisThe Death of Faith?High in the TreesBloody IsleBooks about BodiesNew Lab ManualsIn Brief The Case against Perfection: Ethics in the Age of Genetic Engineering, By Michael J. Sandel

By Peter GwynneSHOW US THE MONEYDespite limited sources of capital, would-be entrepreneurs with solid biobusiness ideas can usually obtain financial support.Art PappasJASON VARNEY | VARNEYPHOTO.COMIt might lack the intellectual cachet of life science in Boston-Cambridge and the Bay area, but North Carolina boasts a significant amount of research in biomedical fields. The work consistently produces both intellectual property and scientist-entrepreneurs eager to exploit it by forming startup compa

By Peter GwynneSHOW US THE MONEYDespite limited sources of capital, would-be entrepreneurs with solid biobusiness ideas can usually obtain financial support.Art PappasJASON VARNEY | VARNEYPHOTO.COMIt might lack the intellectual cachet of life science in Boston-Cambridge and the Bay area, but North Carolina boasts a significant amount of research in biomedical fields. The work consistently produces both intellectual property and scientist-entrepreneurs eager to exploit it by forming startup compa

Award-winning investigative reporter Katherine Eban's work has appeared in the New York Times and The New Yorker. Her first book, Dangerous Doses, exposes the exploits of pharmaceutical drug counterfeiters and polluters. On page 32, she explores the technology recently developed to bolster national security. She notes that "as a country we've spent billions on high-tech security gizmos and helpmates in the war on terror with much less information about whether those gizmos work, and

Want press coverage? Here's what to do - and what not to do.

Credit: DENISE WYLLIE, www.wyllieohagan.com" /> Credit: DENISE WYLLIE, www.wyllieohagan.com WOMEN IN SCIENCE>> The new Rosalind Franklin Society, which aims to encourage women's participation in science, holds its inaugural meeting April 6 at The Rockefeller University in New York City. For more information, E-mail mliebert@liebertpub.com. VACCINE VENTURES>> After you read the feature on global vaccine policy on page 48 register for the Tenth Annual Confer

Rainbow Trout affected by whirling disease." />Rainbow Trout affected by whirling disease. In the early hours of a frigid March morning, a dozen men in waders and coveralls plunge into the icy raceway waters of the Bear Creek fish-rearing station in Accident, Md. Using large plastic baskets, they haul more than 50 pounds at a time of rainbow trout out of the cold water and into even colder air, where the fish are weighed and then tossed into a front-end loader, to be trucked to a plan

Alkis Psaltis has seen more than his share of sheep with the sniffles. Over the past year or two, in the course of researching the role of bacterial biofilms in sinusitis, woolly ruminants with nasal congestion have become almost a daily event for the scientist at the Queen Elizabeth Hospital in Adelaide, Australia. "Basically, the sheep get runny noses," Psaltis explains. "They get a purulent discharge and all the signs of an inflammatory response, including frank pus and friable muc

How not to deal with epidemics.

Knockout mice reveal a path to necrosis.

The paper: F.W. Turek et al., "Obesity and metabolic syndrome in circadian Clock mutant mice." Science, 308:1043, 2005. (Cited in 90 papers) The finding: Joe Bass and others at Northwestern University found that mice with a mutated Clock gene showed both abnormal circadian rhythms and feeding behavior. Metabolic problems included obesity and abnormally high levels of blood cholesterol. The surprise: Circadian variatio

Credit: COURTESY OF ELSEVIER" /> Credit: COURTESY OF ELSEVIER The paper: E. Weisberg et al., "Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl," Cancer Cell, 7:129-41, February 2005. (Cited in 89 papers) The finding: Imatinib (Gleevec) stunned the world with its high cure rate for chronic myeloid leukemia through the inhibition of tyrosine kinase Bcr-Abl. But, BCR-ABL mutations are a common cause of relapse

Credit: © STEPHEN J. KRASEMANN / PHOTO RESEARCHERS, INC" /> Credit: © STEPHEN J. KRASEMANN / PHOTO RESEARCHERS, INC The paper: C. Michaloglou et al., "BRAFE600-associated senescence-like cell cycle arrest of human naevi," Nature, 436:720-4, 2005. (Cited in 92 papers) The finding: Two groups of researchers from the Netherlands teamed up with US colleagues to show that the introduction of oncogene BRAFE600 induced cell-cycle arrest in human

Centocor CEO Neal Fowler learned valuable lessons in sales about straight talk that he hopes will help his company through uncertain times. Just don't ask him about potential layoffs.

NIH is investing millions of dollars in translational cancer research. How can you get involved?

In 1981 Sidney Pestka and colleagues at Roche purified recombinant human leukocyte interferon from bacteria setting the stage for its structure elucidation. Credit: COURTESY OF SIDNEY PESTKA / PBL BIOMEDICAL LABORATORIES" />In 1981 Sidney Pestka and colleagues at Roche purified recombinant human leukocyte interferon from bacteria setting the stage for its structure elucidation. Credit: COURTESY OF SIDNEY PESTKA / PBL BIOMEDICAL LABORATORIES In 1957, Alick Isaacs and Jean Lindenmann, b